Open Access · CC BY-NC 4.0
Competing mortality and the interpretation of similar non-fatal MACE risk with second-generation BTK inhibitors
European Heart Journal – Cardio-Oncology · 2026
DOI: 10.1093/ehjco/aabag014 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Heart Journal – Cardio-Oncology, 2026. Verfasst von Hasan Burak Isleyen und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Isleyen, H. B., & Sucuoglu, Z. (2026). Competing mortality and the interpretation of similar non-fatal MACE risk with second-generation BTK inhibitors. European Heart Journal – Cardio-Oncology. https://doi.org/10.1093/ehjco/aabag014
Vancouver
Isleyen HB, Sucuoglu Z. Competing mortality and the interpretation of similar non-fatal MACE risk with second-generation BTK inhibitors. European Heart Journal – Cardio-Oncology. 2026. doi:10.1093/ehjco/aabag014
BibTeX
@article{Isleyen2026,
author = {Isleyen, Hasan Burak and Sucuoglu, Zehra},
title = {Competing mortality and the interpretation of similar non-fatal MACE risk with second-generation BTK inhibitors},
journal = {European Heart Journal – Cardio-Oncology},
year = {2026},
doi = {10.1093/ehjco/aabag014}
}
EUVIMED